CAS No. |
88901-43-3 |
|---|---|
中文名称 |
(3Β,9β,10α,11α,24R)-24-(β-D-吡喃葡萄糖基氧基)-11,25-二羟基-9-甲基-19-去甲羊毛甾-5-烯-3-基6-O-β-D-吡喃葡萄糖基-β-D-吡喃葡萄糖苷 |
英文名称 |
(3Β,9β,10α,11α,24R)-24-(β-D-glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-3-yl 6-O-β-D-glucopyranosyl-β-D-glucopyranoside |
别名 |
Mogroside III-A2 | Mogroside III A2 |
标准英文名 |
(2R,3R,4S,5S,6R)-2-(((3R,8S,9S,10S,11S,13R,14S,17R)-11-hydroxy-17-((2R,5R)-6-hydroxy-6-methyl-5-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)heptan-2-yl)-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol |
MDL No. |
MFCD34470884 |
分子式 |
C48H82O19 |
分子量 |
963.16 |
精确分子量 |
962.55 |
SMILES |
C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@H](CC[C@@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@@]3(C)[C@@H](O)C[C@]12C |
标准SMILES |
C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@H](CC[C@@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@@]3(C)[C@@H](O)C[C@@]21C |
用途 |
Mogroside IIIA2 can inhibit the activation of Epstein-Barr virus early antigen (EBV-EA); it exhibits weak inhibitory activity against NOR1 activation. |
InChIKey |
PASFPXYDHLIVRF-QXNKNHBFSA-N |
|
|
评论 |
|---|